While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
Dx Deal Roundup: A Major Proteomics Merger, Ginkgo Makes Pharma Inroads, and More Legal Woes for Illumina
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.